SCHEDULE 13G/A 0001890802 XXXXXXXX LIVE 1 Common stock, par value $0.0001 12/31/2024 0000034956 Tenax Therapeutics, Inc. 88032L605 101 Glen Lennox Drive, Suite 300 Chapel Hill NC 27517 Rule 13d-1(c) S.H.N. Financial Investments Ltd. L3 179050.00 0.00 179050.00 0.00 179050.00 N 4.99 FI Tenax Therapeutics, Inc. 101 Glen Lennox Drive, Suite 300 Chapel Hill, NC 27517 S.H.N. Financial Investments Ltd. Herzliya Hills Arik Einstein 3, Israel, 4610301 Israel Y 179,050 This amendment refers to a Schedule 13G filed with the Securities and Exchange Commission on February 20, 2024, covering 107,000 shares of Common Stock purchased and underlying warrants purchased on February 8, 2024. The amounts in Row (5), (7) and (9) represent 179,050 Warrants to purchase Common Stock, which are subject to a 4.99% beneficial ownership limitation. Does not include 174,950 Warrants to purchase Common Stock, which are subject to a 4.99% beneficial ownership limitation. The percentage set forth on Row (11) of the cover page for the reporting person is based on 3,408,906 Common Stock outstanding as of October 31, 2024, based upon the Issuer's Quarterly Report on Form 10-Q for the quarter ended September 30, 2024, filed with the Securities and Exchange Commission on November 13, 2024. Nir Shamir is the Chief Executive Officer of SHN. As such, SHN and Mr. Shamir may be deemed to beneficially own (as that term is defined in Rule 13d-3 under the Securities Exchange Act of 1934) the securities described herein. To the extent Mr. Shamir is deemed to beneficially own such securities, Mr. Shamir disclaims beneficial ownership of these securities for all other purposes. 4.99% 179,050 0 179,050 0 N Y Y Y Y Y N By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11. S.H.N. Financial Investments Ltd. /s/ Nir Shamir 03/18/2025